Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dexmedetomidine on the Prevention of Delirium
IRCT20160307026950N77Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in delirium, sponsored by Isfahan University of Medical Sciences. Started Jan 2026; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20160307026950N77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N77.